DA Davidson Initiated Macatawa Bank (MCBC)’s Coverage with $13 Target; Valeritas Holdings (VLRX) Shorts Increased By 223.81%

Macatawa Bank Corporation (NASDAQ:MCBC) Logo

Stock research analysts at DA Davidson placed “Neutral” rating on Macatawa Bank (NASDAQ:MCBC). The firm has begun coverage in analysts note issued to investors and clients on Friday, 29 June. DA Davidson’s target would suggest upside of 6.38% from the company’s previous stock close.

Valeritas Holdings Inc (NASDAQ:VLRX) had an increase of 223.81% in short interest. VLRX’s SI was 13,600 shares in June as released by FINRA. Its up 223.81% from 4,200 shares previously. With 9,200 avg volume, 2 days are for Valeritas Holdings Inc (NASDAQ:VLRX)’s short sellers to cover VLRX’s short positions. The SI to Valeritas Holdings Inc’s float is 0.57%. The stock decreased 2.84% or $0.04 during the last trading session, reaching $1.37. About 803,364 shares traded. Valeritas Holdings, Inc. (NASDAQ:VLRX) has declined 68.29% since June 29, 2017 and is downtrending. It has underperformed by 80.86% the S&P500. Some Historical VLRX News: 09/05/2018 – Valeritas Holdings 1Q Rev $6.08M; 18/05/2018 – VALERITAS HOLDINGS INC – IMPROVEMENTS IN A1C WERE NOTED ACROSS A WIDE RANGE OF BASELINE INSULIN DOSES IN TRIAL; 28/03/2018 VALERITAS HOLDINGS INC VLRX.O : COWEN AND COMPANY CUTS TO MARKET PERFORM FROM OUTPERFORM; 23/05/2018 – Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Positive Clinical and Economic Benefits in Patients with Type; 18/05/2018 – Valeritas Announces Positive Clinical Results Across Two New Studies Evaluating V-Go® Wearable Insulin Delivery Device in Pati; 21/05/2018 – VALERITAS HOLDINGS INC – MED TRUST WILL HAVE RIGHTS TO PROMOTE, MARKET AND SELL V-GO TO DIABETES CLINICS AND PATIENTS IN AUSTRIA AND GERMANY; 18/05/2018 – VALERITAS HOLDINGS – IN TRIAL, AFTER THREE MONTHS OF V-GO USE, SIGNIFICANT REDUCTIONS WERE OBSERVED IN BOTH A1C AND TDD; 09/05/2018 – Valeritas Reports Record First Quarter Revenue with 32% Year-over-Year Growth and Gross Margins Expand to Record 47.6%; 30/04/2018 – Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2; 18/05/2018 – Valeritas Announces Positive Clinical Results Across Two New Studies Evaluating V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes

More notable recent Valeritas Holdings, Inc. (NASDAQ:VLRX) news were published by: Streetinsider.com which released: “Pre-Open Movers 06/25: (XRM) (VLRX) (GTN) Higher; (SPHS) (MACK) (ATI) Lower (more…)” on June 25, 2018, also Nasdaq.com with their article: “Mid-Morning Market Update: Markets Open Lower; Carnival Cuts Profit Forecast” published on June 25, 2018, Nasdaq.com published: “Valeritas ENABLE Study Demonstrates Significant Clinical Benefits of V-Go in Patients with Type 2 Diabetes Who …” on June 25, 2018. More interesting news about Valeritas Holdings, Inc. (NASDAQ:VLRX) were released by: Benzinga.com and their article: “44 Biggest Movers From Yesterday” published on June 26, 2018 as well as Benzinga.com‘s news article titled: “36 Stocks Moving In Monday’s Mid-Day Session” with publication date: June 25, 2018.

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. The company has market cap of $33.85 million. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. It currently has negative earnings. The firm also develops h-Patch, a controlled delivery technology platform; Mini-Ject, a disposable needle-free injection system that delivers drugs ranging from small molecules to large proteins, as well as antibodies and vaccines; and Micro-Trans microneedle array patch technology to deliver drugs into the dermis layer of the skin.

Macatawa Bank Corporation operates as the bank holding firm for Macatawa Bank that provides commercial and personal banking services primarily in Western Michigan. The company has market cap of $415.69 million. The companyÂ’s deposit products include checking accounts, savings accounts and time deposits, transaction accounts, regular and money market savings accounts, and certificates of deposit. It has a 23.59 P/E ratio. The Company’s loan products portfolio comprises commercial and industrial loans offered to finance activities and equipment; commercial real estate loans primarily comprising construction and development loans, and multi-family and other non-residential real estate loans; retail loans that primarily consist of residential mortgage loans; and consumer loans, including automobile loans, home equity lines of credit and installment loans, home improvement loans, deposit account loans, and other loans for household and personal purposes.

Investors sentiment decreased to 1.12 in 2018 Q1. Its down 0.03, from 1.15 in 2017Q4. It dived, as 6 investors sold Macatawa Bank Corporation shares while 19 reduced holdings. 9 funds opened positions while 19 raised stakes. 9.46 million shares or 3.41% more from 9.14 million shares in 2017Q4 were reported. Millennium Mgmt Limited has invested 0% in Macatawa Bank Corporation (NASDAQ:MCBC). Aspen Invest Management stated it has 10,095 shares. Renaissance Ltd Liability Corp invested in 0.01% or 1.10M shares. Stone Ridge Asset Management Limited Liability holds 0.01% of its portfolio in Macatawa Bank Corporation (NASDAQ:MCBC) for 13,628 shares. Panagora Asset Mgmt reported 314,065 shares. State Street holds 470,067 shares or 0% of its portfolio. Credit Suisse Ag invested in 10,802 shares or 0% of the stock. Meeder Asset owns 0% invested in Macatawa Bank Corporation (NASDAQ:MCBC) for 810 shares. Amer Century invested in 18,130 shares. Morgan Stanley accumulated 301,758 shares or 0% of the stock. Ny State Common Retirement Fund has 24,100 shares for 0% of their portfolio. Wells Fargo & Mn reported 41,116 shares stake. Great West Life Assurance Can, Manitoba – Canada-based fund reported 204 shares. Commercial Bank Of America Corp De reported 72,757 shares. Geode Cap Mngmt Lc invested in 178,257 shares or 0% of the stock.

Macatawa Bank Corporation (NASDAQ:MCBC) Institutional Positions Chart